The Effect of Montelukast and Low-Dose Theophylline on Cardiovascular Disease Risk Factors in Asthmatics
- 1 September 2007
- Vol. 132 (3), 868-874
- https://doi.org/10.1378/chest.07-0831
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Clinical Trial of Low-Dose Theophylline and Montelukast in Patients with Poorly Controlled AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Lung Function and Ischemic Stroke IncidenceChest, 2006
- High sensitivity C-reactive protein in asthmaEuropean Respiratory Journal, 2006
- Leukotriene receptors in atherosclerosisAnnals of Medicine, 2006
- Inflammatory Markers and the Risk of Coronary Heart Disease in Men and WomenNew England Journal of Medicine, 2004
- Are patients with asthma at increased risk of coronary heart disease?International Journal of Epidemiology, 2004
- Chlamydia pneumoniae Infection and Inflammation in Adults with AsthmaRespiration, 2004
- 5-Lipoxygenase and atherosclerosisCurrent Opinion in Lipidology, 2003
- C-reactive protein, inflammation, and coronary riskCardiology Clinics, 2003
- Asthma, Body Mass Index, and C-Reactive Protein Among US AdultsJournal of Asthma, 2003